Hillsdale Investment Management Inc. Liquidia Corp Transaction History
Hillsdale Investment Management Inc.
- $1.13 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding LQDA
# of Institutions
161Shares Held
35.5MCall Options Held
1.68MPut Options Held
1.17M-
Patient Square Capital LP Menlo Park, CA7.18MShares$83.4 Million45.11% of portfolio
-
Black Rock Inc. New York, NY3.75MShares$43.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$33.5 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.25MShares$26.1 Million3.48% of portfolio
-
Findell Capital Management LLC New York, NY2.11MShares$24.4 Million16.28% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $747M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...